Bacteriophage Endolysins Antibacterial Effect against S. mutans Isolated from Dental Caries: An In-Vitro Study

Huda Mohammad Hasan Ali, Adeeb Ahmed kadhim Al-Zubaidy, Ahmed Sahib Abdulamir

Abstract


Background: Many bacterial infections including dental caries that caused by Streptococcus mutans (S. mutans) were difficult to be treated due to the unavailability of effective antibiotics. Therefore, it requires to focus the attention on endolysin as an antibacterial agent. This study was designed to evaluate the In-vitro  effectiveness of specific bacteriophage endolysins against S. mutans isolated from dental caries.

Methods: Twenty-five isolates of S. mutans were collected from patients with dental caries attended to Al-Imamain Al-Kadhimain, Medical City Hospital, and AL-Ameen Health Center, during the period from December 2021 to May 2022. The S. mutans isolates were identified by culturing them on their specific mitis salivarius sucrose bacitracin tellurite media (MS-SBT agar), morphological characteristics, gram staining, biochemical tests and VITEK 2 compact system. Seven of these S. mutans isolates were used for the in-vitro study.

Results: The bacteriophage endolysin enzyme extracted from the corresponding S. mutans isolate was effective as In-vitro  antibacterial agent with minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) ranging between (13.63 – 17.83) µg/ml and (17.04-22.28) µg/ml respectively.

Conclusion: The endolysin was effective as antibacterial agent against multi-drug resistant (MDR) S. mutans upon growing and testing on culture media.


Full Text:

PDF

References


Loessner MJ, Kramer K, Ebel F, Scherer S. C-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high-affinity binding to bacterial cell wall carbohydrates. Molecular Microbiology, (2002); 44(2): 335-349.

Banas JA. Virulence properties of Streptococcus mutans. Frontiers in Biosciences, (2004); 9: 1267-1277.

Clark JR, March JB. Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials. Trends in Biotechnology, (2006). 24(5): 212-218.

Ackermann HW. Tailed bacteriophages: the order caudovirales. Advances in Virus Research, (1998); 51: 135-201.

Inal JM. Phage therapy: a reappraisal of bacteriophages as antibiotics. ArchivumImmunologiae et TherapiaeExperimentalis(Warsz), (2003); 51(4): 237-244. (PMID: 12956433).

Fischetti VA. Lysin Therapy for Staphylococcus aureus and Other Bacterial Pathogens. Currrnt Topics in Microbiology and Immunology, (2017); 409: 529-540.

Fischetti VA. Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens. International Journal of Medical Microbiology, 2010; 300(6): 357-362.

Cahill J, Young R. Phage Lysis: Multiple Genes for Multiple Barriers. Advces in Virus Research, (2019); 103: 33-70.

Wang IN, Smith DL, Young R. Holins: the protein clocks of bacteriophage infections. Annual Reviews in Microbiology, (2000); 54: 799-825.

Ezzeldin N, Elshishtawy H, Mohamed M. Molecular assessment of oral Streptococcus mutans isolated from patients with different ages and caries activity via selective media and protein pattern. Egyptian Dental Journal, (2021); 67: 780-800.

Budzik JM, Rosche WA, Rietsch A, O'Toole GA. Isolation and characterization of a generalized transducing phage for Pseudomonas aeruginosa strains PAO1 and PA14. Journal of Bacteriology, (2004); 186(10): 3270-3273.

Virgen-Ortíz JJ, Ibarra-Junquera V, Osuna-Castro JA, Escalante-Minakata P, Mancilla-Margalli NA, Ornelas-Paz Jde J. Method to concentrate protein solutions based on dialysis-freezing-centrifugation: enzyme applications. Analytical Biochemistry, (2012); 426(1): 4-12.

Lakshmi BKM, Muni Kumar D, Hemalatha KPJ. Purification and characterization of alkaline protease with novel properties from Bacillus cereus strain S8. Journal of Genetic Engineering and Biotechnology, (2018); 16(2): 295-304.

Harley JP. Colony Forming Unit and Calculation. Laboratory Exercises in Microbiology. McGraw-Hill Higher Education; 6th Edition; 1 April 2004.

Ali MR, Abdulamir AS, Kadhim SR. Extraction, purification and therapeutic use of bacteriophage endolysin against multi-drug resistant Staphylococcus aureus: In vivo and In-vitro study. Journal of Contemporary Medical Sciences, (2018): 4 (1): 33– 38.

Rashel M, Uchiyama J, Ujihara T, Uehara Y, Kuramoto S, Sugihara S, et al. Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11. Journal of Infectious Diseases, (2007); 196(8): 1237-1247.

Hussain HE, Abdulamir AS, Farhood IG, Ali AR, Al-azzawy MA. In-vitro and in vivo study for antibacterial activity of endolysin-HEC gel and mixture gel on acne vulgaris caused by multidrug-resistant Staphylococcus aureus bacteria. Journal of Population Therapeutics and Clinical Pharmacology, (2023); 30(1): e242–e257.

Oliveira H, São-José C, Azeredo J. Phage-Derived Peptidoglycan Degrading Enzymes: Challenges and Future Prospects for In Vivo Therapy. Viruses, (2018); 10(6):292.




DOI: http://dx.doi.org/10.62940/als.v11i2.2662

Refbacks

  • There are currently no refbacks.